QA: Altrazeal Life Sciences Inc in us_pharma/2012

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001168220_2013_Altrazeal_Life_Sciences_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning The EntityCommonStockSharesOutstanding does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0001168220, Altrazeal Life Sciences Inc

  xvar xval
0 AssetsCurrent 1,115,982
1 IntangibleAssetsNetIncludingGoodwill 4,145,985
2 PropertyPlantAndEquipmentNet 845,535
3 remainder_Assets 1,220,615
4 LiabilitiesCurrent 3,889,734
5 LiabilitiesNoncurrent 1,587,096
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 1,791,221
9 ResearchAndDevelopmentExpense 832,931
10 remainder_Expenses 1,339,510
11 remainder_Revenues 370,594
12 remainder_NetIncome 61,719
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 7,328,117
1 Liabilities 5,476,830
2 Expenses 3,963,662
3 Revenues 370,594
4 StockholdersEquity 1,851,287
5 NetIncome -3,531,349
6 ComprehensiveNetIncome -3,531,349
7 BaseVar 8,600,461
8 EconomicCapitalRatiobeforeLimitedLiability 0.0788
9 EconomicCapitalRatio 1.49

Edgar->Model Mapping

Feature Distribution

Change over Time